Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10
25.00p
(1.31%)
- Add to watchlist
- Create an alert
- This stock can be held in a
25.00p
(1.31%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
25.00p
(1.31%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1,904.00p
1,912.00p
2,165.00p
£4.17 bn
1,904.00p
1,879.00p
1,711.00p
11.20
1.00p (0.05%) Previous:
1.00p
171,612
3.05%
500
Performance
| 1 week 1W | 0.42% | 1 year 1Y | 5.93% |
|---|---|---|---|
| 1 month 1M | 3.69% | 2 years 2Y | 42.3% |
| 3 months 3M | 3.99% | 3 years 3Y | 20.13% |
| 6 months 6M | 1.76% | 5 years 5Y | 7.89% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue ($m) | 2,875.00 | 2,517.00 |
| Profit before tax ($m) | 281.00 | 233.00 |
| Adjusted EPS (¢): | 223.00 | 181.00 |
| P/E ratio | 10.50 | 11.20 |
| PEG | 0.50 | n/a |
| EPS growth (%) | 23.00 | (7.00) |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by Hikma Pharmaceuticals:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Interim | 15/08/2024 | 20/09/2024 | 32.00¢ |
| Final | 21/03/2024 | 03/05/2024 | 47.00¢ |
| Interim | 10/08/2023 | 15/09/2023 | 25.00¢ |
| Final | 23/03/2023 | 05/05/2023 | 37.00¢ |
| Interim | 18/08/2022 | 20/09/2022 | 19.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Hikma Pharmaceuticals dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2023 | 3.10% | 3.10 | $0.72 |
| 31/12/2022 | 2.80% | 3.23 | $0.56 |
| 31/12/2021 | 1.90% | 3.61 | $0.54 |
| 31/12/2020 | 1.50% | 3.46 | $0.50 |
| 31/12/2019 | 1.70% | 3.42 | $0.44 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
There are no documents available for this stock.
-
London close: Stocks slip as investors digest UK, US data
3 September 2024 15:51
-
Berenberg upgrades Hikma Pharmaceuticals to 'buy'
3 September 2024 09:44
-
London close: Stocks buoyed by solid economic data
15 August 2024 15:30
-
Block listing Interim Review
1 October 2024 09:45
-
Director/PDMR Shareholding
24 September 2024 10:09
-
Hikma completes Xellia acquisition
10 September 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.